Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Status and Forecast 2020-2026

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Autologous Stem Cell Therapy
1.4.3 Non-Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Neurodegenerative Disorders
1.5.4 Cardiovascular Disease
1.5.5 Autoimmune Diseases
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Autologous Stem Cell and Non-Stem Cell Based Therapies Industry
1.6.1.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Autologous Stem Cell and Non-Stem Cell Based Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Autologous Stem Cell and Non-Stem Cell Based Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Perspective (2015-2026)
2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Growth Trends by Regions
2.2.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Autologous Stem Cell and Non-Stem Cell Based Therapies Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Market Size
3.1.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue (2015-2020)
3.1.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio
3.2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2019
3.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players Head office and Area Served
3.4 Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service
3.5 Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Type (2015-2020)
4.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2021-2026)
5 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Application (2015-2026)
5.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020)
5.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2015-2020)
6.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players in North America (2019-2020)
6.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020)
6.4 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020)
7 Europe
7.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2015-2020)
7.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players in Europe (2019-2020)
7.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020)
7.4 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020)
8 China
8.1 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2015-2020)
8.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players in China (2019-2020)
8.3 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020)
8.4 China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020)
9 Japan
9.1 Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2015-2020)
9.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players in Japan (2019-2020)
9.3 Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020)
9.4 Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020)
10 Mid East & Africa
10.1 Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2015-2020)
10.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players in Mid East & Africa (2019-2020)
10.3 Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020)
10.4 Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020)
11 Australia
11.1 Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2015-2020)
11.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players in Australia (2019-2020)
11.3 Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020)
11.4 Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020)
12 Key Players Profiles
12.1 Fibrocell Science, Inc.
12.1.1 Fibrocell Science, Inc. Company Details
12.1.2 Fibrocell Science, Inc. Business Overview and Its Total Revenue
12.1.3 Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.1.4 Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020))
12.1.5 Fibrocell Science, Inc. Recent Development
12.2 Vericel Corporation
12.2.1 Vericel Corporation Company Details
12.2.2 Vericel Corporation Business Overview and Its Total Revenue
12.2.3 Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.2.4 Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.2.5 Vericel Corporation Recent Development
12.3 Dendreon Corporation (Sanpower Group)
12.3.1 Dendreon Corporation (Sanpower Group) Company Details
12.3.2 Dendreon Corporation (Sanpower Group) Business Overview and Its Total Revenue
12.3.3 Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.3.4 Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.3.5 Dendreon Corporation (Sanpower Group) Recent Development
12.4 Caladrius Biosciences, Inc.
12.4.1 Caladrius Biosciences, Inc. Company Details
12.4.2 Caladrius Biosciences, Inc. Business Overview and Its Total Revenue
12.4.3 Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.4.4 Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.4.5 Caladrius Biosciences, Inc. Recent Development
12.5 BrainStorm Cell Therapeutics
12.5.1 BrainStorm Cell Therapeutics Company Details
12.5.2 BrainStorm Cell Therapeutics Business Overview and Its Total Revenue
12.5.3 BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.5.4 BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.5.5 BrainStorm Cell Therapeutics Recent Development
12.6 Regeneus Ltd.
12.6.1 Regeneus Ltd. Company Details
12.6.2 Regeneus Ltd. Business Overview and Its Total Revenue
12.6.3 Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.6.4 Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.6.5 Regeneus Ltd. Recent Development
12.7 Genzyme Corporation
12.7.1 Genzyme Corporation Company Details
12.7.2 Genzyme Corporation Business Overview and Its Total Revenue
12.7.3 Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.7.4 Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.7.5 Genzyme Corporation Recent Development
12.8 Pluristem Therapeutics Inc
12.8.1 Pluristem Therapeutics Inc Company Details
12.8.2 Pluristem Therapeutics Inc Business Overview and Its Total Revenue
12.8.3 Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.8.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.8.5 Pluristem Therapeutics Inc Recent Development
12.9 U.S. Stem Cell, Inc
12.9.1 U.S. Stem Cell, Inc Company Details
12.9.2 U.S. Stem Cell, Inc Business Overview and Its Total Revenue
12.9.3 U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.9.4 U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.9.5 U.S. Stem Cell, Inc Recent Development
12.10 TiGenix (Takeda)
12.10.1 TiGenix (Takeda) Company Details
12.10.2 TiGenix (Takeda) Business Overview and Its Total Revenue
12.10.3 TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
12.10.4 TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
12.10.5 TiGenix (Takeda) Recent Development
13 Analyst's Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details
List of Tables
Table 1. Autologous Stem Cell and Non-Stem Cell Based Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue
Table 3. Ranking of Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Autologous Stem Cell Therapy
Table 6. Key Players of Non-Stem Cell Therapy
Table 7. COVID-19 Impact Global Market: (Four Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Autologous Stem Cell and Non-Stem Cell Based Therapies Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Autologous Stem Cell and Non-Stem Cell Based Therapies Players to Combat Covid-19 Impact
Table 12. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2015-2020)
Table 16. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Strategy
Table 22. Main Points Interviewed from Key Autologous Stem Cell and Non-Stem Cell Based Therapies Players
Table 23. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue by Players (2015-2020) (Million US$)
Table 24. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players (2015-2020)
Table 25. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2019)
Table 26. Global Autologous Stem Cell and Non-Stem Cell Based Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service
Table 29. Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 32. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Share by Type (2015-2020)
Table 33. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2021-2026)
Table 34. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Share by Application (2015-2020)
Table 35. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 36. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Share by Application (2021-2026)
Table 37. North America Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share (2019-2020)
Table 39. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 40. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 41. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 42. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 43. Europe Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share (2019-2020)
Table 45. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 47. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 49. China Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 50. China Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share (2019-2020)
Table 51. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 52. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 53. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 54. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 55. Japan Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share (2019-2020)
Table 57. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 59. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 61. Mid East & Africa Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 62. Mid East & Africa Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share (2019-2020)
Table 63. Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 64. Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 65. Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 66. Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 67. Australia Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 68. Australia Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share (2019-2020)
Table 69. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 70. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 71. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 72. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 73. Fibrocell Science, Inc. Company Details
Table 74. Fibrocell Science, Inc. Business Overview
Table 75. Fibrocell Science, Inc. Product
Table 76. Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 77. Fibrocell Science, Inc. Recent Development
Table 78. Vericel Corporation Company Details
Table 79. Vericel Corporation Business Overview
Table 80. Vericel Corporation Product
Table 81. Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 82. Vericel Corporation Recent Development
Table 83. Dendreon Corporation (Sanpower Group) Company Details
Table 84. Dendreon Corporation (Sanpower Group) Business Overview
Table 85. Dendreon Corporation (Sanpower Group) Product
Table 86. Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 87. Dendreon Corporation (Sanpower Group) Recent Development
Table 88. Caladrius Biosciences, Inc. Company Details
Table 89. Caladrius Biosciences, Inc. Business Overview
Table 90. Caladrius Biosciences, Inc. Product
Table 91. Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 92. Caladrius Biosciences, Inc. Recent Development
Table 93. BrainStorm Cell Therapeutics Company Details
Table 94. BrainStorm Cell Therapeutics Business Overview
Table 95. BrainStorm Cell Therapeutics Product
Table 96. BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 97. BrainStorm Cell Therapeutics Recent Development
Table 98. Regeneus Ltd. Company Details
Table 99. Regeneus Ltd. Business Overview
Table 100. Regeneus Ltd. Product
Table 101. Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 102. Regeneus Ltd. Recent Development
Table 103. Genzyme Corporation Company Details
Table 104. Genzyme Corporation Business Overview
Table 105. Genzyme Corporation Product
Table 106. Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 107. Genzyme Corporation Recent Development
Table 108. Pluristem Therapeutics Inc Business Overview
Table 109. Pluristem Therapeutics Inc Product
Table 110. Pluristem Therapeutics Inc Company Details
Table 111. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 112. Pluristem Therapeutics Inc Recent Development
Table 113. U.S. Stem Cell, Inc Company Details
Table 114. U.S. Stem Cell, Inc Business Overview
Table 115. U.S. Stem Cell, Inc Product
Table 116. U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 117. U.S. Stem Cell, Inc Recent Development
Table 118. TiGenix (Takeda) Company Details
Table 119. TiGenix (Takeda) Business Overview
Table 120. TiGenix (Takeda) Product
Table 121. TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 122. TiGenix (Takeda) Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type: 2020 VS 2026
Figure 2. Autologous Stem Cell Therapy Features
Figure 3. Non-Stem Cell Therapy Features
Figure 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Neurodegenerative Disorders Case Studies
Figure 7. Cardiovascular Disease Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. Autologous Stem Cell and Non-Stem Cell Based Therapies Report Years Considered
Figure 11. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions: 2020 VS 2026
Figure 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players in 2019
Figure 16. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2019
Figure 18. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Mid East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Fibrocell Science, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Fibrocell Science, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 26. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Vericel Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 28. Dendreon Corporation (Sanpower Group) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Dendreon Corporation (Sanpower Group) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 30. Caladrius Biosciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Caladrius Biosciences, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 32. BrainStorm Cell Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 34. Regeneus Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Regeneus Ltd. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 36. Genzyme Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Genzyme Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 38. Pluristem Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pluristem Therapeutics Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 40. U.S. Stem Cell, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. U.S. Stem Cell, Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 42. TiGenix (Takeda) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. TiGenix (Takeda) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs